642-78-4

642-78-4 structure
642-78-4 structure
  • Name: Cloxacillin Sodium
  • Chemical Name: cloxacillin sodium
  • CAS Number: 642-78-4
  • Molecular Formula: C19H17ClN3NaO5S
  • Molecular Weight: 475.878
  • Catalog: Organic raw materials Inorganic acid ester
  • Create Date: 2018-03-05 08:00:00
  • Modify Date: 2026-06-30 19:26:11
  • Cloxacillin sodium exhibits antibiotic efficacy, with a MIC of 256 mg/L for Staphylococcus aureus 25923[1][2][3].

Name cloxacillin sodium
Synonyms austrastaph
Tegopen
Cloxacillin-13C4 Sodium
ankerbin
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, sodium salt, (2S,5R,6R)-, hydrate (1:1:1)
Sodium cloxacillin
cloxacillin sodium hydrate
Cloxapen
(2S
Austrastaph
[5-METHYL-3-(O-CHLOROPHENYL)-4-ISOXAZOLYL]PENICILLIN SODIUM SALT MONOHYDRATE
prostaphlina
Prevencilina P
Cloxacillin sodium salt hydrate
staphybiotic
Oxacillin Impurity E(Sodium salt)
Oxacillin Impurity 5 Sodium Salt (Cloxacillin Sodium Salt)
brl-1621sodiumsalt
ekvacillin
Sodium 3-(O-chlorophenyl)-5-methyl-4-isoxazolylpenicillin
Sodium cloxacillin monohydrate
syntpensodiumsalt
cloxacillin sodium monohydrate
CLOXACILLIN SODIUM SALT HYDRATE
prevencilinap
3-o-chlorophenyl-5-methyl-4-isoxazolylpenicillinsodium
sodium 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]htane-2-cboxylate
CLOXACILLIN SODIUM SALT N-HYDRATE
monosodiumcloxacillin
[(2S,5R,6R)-6-({[3-(2-Chlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylato-κO]sodium hydrate (1:1)
sodium, [(2S,5R,6R)-6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylato-κO]-, hydrate (1:1)
3-dimethyl-7-oxo-thyl-4-isoxazolecboxamido)-monosodiumsalt
Gelstaph
CLOXACILLINSODIUMPOWDER/COMPACTED/STERILELYOPHILED
2-Dipalmitoyl-sn-glycerol-3-Phosphoethanolamine
prostaphilina
2-Dipalmitoyl-sn-glycero-3-PE
Thiazole sodium chloride
sodiumsyntpen
Cloxacillin-13C4 SodiuM Salt
Cloxacillin-13C4 Sodium SaltQ: What is Cloxacillin-13C4 Sodium Salt Q: What is the CAS Number of Cloxacillin-13C4 Sodium Salt
4-Thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid, 6-[3-(o-chlorophenyl)-5-methyl-4-isoxazolecboxamido]-3,3-dimethyl-7-oxo-, monosodium salt (8CI)
cloxapen
Phenylbutazone Impurity 30
(2S,5R,6R)-6-[[[3-(2-Chlorophenyl)-5-Methyl-4-isoxazolyl]carbonyl]amino]-3,3-diMethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]htane-2-cboxylic Acid SodiuM Salt
Cloxacillin-13C4 SodiuM Salt //BP
3-(o-Chlorophenyl)-5-Methyl-4-isoxazolylpenicillin-13C
Staphybiotic
(2S,5R)-6α-[[[3-(2-Chlorophenyl)-5-methylisoxazol-4-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]htane-2β-cboxylic acid sodium salt
Ankerbin
orbeninsodium
3-(o-Chlorophenyl)-5-methyl-4-isoxazolylpenicillin sodium salt
(2S,5R,6R)-6-[[[3-(2-Chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Sodium Salt Monohydrate
gelstaph
SODIUMCLOXACILLIN(ANHYDROUS)
(2S,5R,6R)-6-[[[3-(2-Chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid monosodium salt
2-DPPE
(2S,5R,6R)-6-[[[3-(2-Chlorophenyl)-5-Methyl-4-isoxazolyl]carbonyl]amino]-3,3-diMethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]htane-2-cboxylic Acid-13C4 SodiuM Salt
4R)-Methyl 3-((R)-1-acetaMido-2-ethylbutyl)-4-amino-2-hydroxycyclopentanecboxylate
CLOXACILLIN SODIUM SALT MONOHYDRATE
4-Thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, sodium salt (1:1), (2S,5R,6R)
Cloxacillin sodium salt
(S)-(-)-Dropropizine-d4
Orbenin
Sodium (2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrate (1:1:1)
MFCD00150735
Prostaphilin A
4-Thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, monosodium salt, [2S-(2α,5α,6β)]
tegopen
Ekvacillin
Cloxacillin Sodium Salt
Cloxacillin sodium anhydrous
Oxacillin Impurity 17 Sodium Salt
EINECS 211-390-9
4-Thia-1-azabicyclo3.2.0htane-2-cboxylic acid, -(2-chlorophenyl)-5-methyl-4-isoxazolylcbonylamino-3,3-dimethyl-7-oxo-, monosodium salt, (2S,5R,6R)
4-Acetyloxy-N-despropyl Ropivacaine
Monosodium (2S,5R,6R)-6-(3-(o-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Monohydrate
4S)-Sacubitril
sodiumorbenin
Description Cloxacillin sodium exhibits antibiotic efficacy, with a MIC of 256 mg/L for Staphylococcus aureus 25923[1][2][3].
Related Catalog
In Vitro Cloxacillin is an antibiotic useful for the study of a number of bacterial infections[1]. Cell Viability Assay[1] Cell Line: Strains M12 and M60. Concentration: 0.5 μg/mL. Incubation Time: 4-24 h. Result: Significantly reduced the bacterial numbers.
In Vivo Cloxacillin sodium (50 mg/kg, Subcutaneously) results a significant antibiotic efficacy against S. aureus[3] Animal Model: Mice[2]. Dosage: 10 mg/kg (Pharmacological Analysis). Administration: Given subcutaneously. Result: Reached a maximal concentration in plasma of 8.4 μg/mL at 10 min and had a half-life of approximately 15 min. Animal Model: Mice injected with approximately 2 × 106 CFU of bacteria in 0.1 mL saline were aseptically injected into the right thigh muscle[3]. Dosage: 0–500 mg/kg. Administration: Subcutaneously in the nuchal region at 1 h after infection. Result: Resulted in a significant decrease in the number of viable S. aureus measured 18 h thereafter.
References

[1]. J C Anderson, et al. The Effect of Incorporation of Cloxacillin in Liposomes on Treatment of Experimental Staphylococcal Mastitis in Mice. J Vet Pharmacol Ther. 1986 Sep;9(3):303-9.

[2]. W Calame, et al. Influence of Etoposide and Cyclophosphamide on the Efficacy of Cloxacillin and Erythromycin in an Experimental Staphylococcal Infection. Antimicrob Agents Chemother. 1989 Jun;33(6):980-2.

[3]. Peter H Nibbering, et al. 99mTc-Labeled UBI 29-41 Peptide for Monitoring the Efficacy of Antibacterial Agents in Mice Infected With Staphylococcus Aureus. J Nucl Med. 2004 Feb;45(2):321-6.

Melting Point 170ºC
Molecular Formula C19H17ClN3NaO5S
Molecular Weight 475.878
Exact Mass 475.058075
PSA 140.87000
LogP 1.54280
Storage condition 2-8°C
Stability Stable. Incompatible with strong oxidizing agents. Refrigerate.
Water Solubility H2O: 50 mg/mL, clear, colorless

CHEMICAL IDENTIFICATION

RTECS NUMBER :
XH8750000
CHEMICAL NAME :
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(3-(o-chlorophenyl)-5-methyl- 4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-, monosodium salt
CAS REGISTRY NUMBER :
642-78-4
LAST UPDATED :
199806
DATA ITEMS CITED :
10
MOLECULAR FORMULA :
C19-H17-C1-N3-O5-S.Na
MOLECULAR WEIGHT :
434.45
WISWESSER LINE NOTATION :
T45 ANV ESTJ F1 F1 GVQ CMV- DT5NOJ C1 ER BG &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,232,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1350 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 15,322,1965
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
4200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,232,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1660 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,232,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,232,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1170 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,232,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,232,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
916 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - ataxia Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
FATOAO Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- Volume(issue)/page/year: 31,232,1968
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1117 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,401,1995 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4495 No. of Facilities: 203 (estimated) No. of Industries: 2 No. of Occupations: 8 No. of Employees: 4409 (estimated) No. of Female Employees: 2017 (estimated)
Hazard Codes Xn
Risk Phrases 36/37/38-42/43
Safety Phrases S22
WGK Germany 2
RTECS XH8920000
HS Code 2941109900

~%

642-78-4 structure

642-78-4

Literature: WO2012/164355 A1, ; Page/Page column 9-10 ;

~%

642-78-4 structure

642-78-4

Literature: WO2012/164355 A1, ;

~%

642-78-4 structure

642-78-4

Literature: WO2012/164355 A1, ;
HS Code 2941109900
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.